The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
it's not changed, it's the 26th, the date shown under "pxs share news" is utter ******, which isn't unusual for alliance news.
Has the date of the AGM changed?
Says its Monday Monday 23rd October on here, but the Provexis website has it as the 26th.
Love your Heart with Dr Hilary.
https://www.healthspan.co.uk/advice/heart-health/
If Provexis has already purchased €550k of stock then that would leave around the same amount at DSM.
"The Company and DSM have been in further negotiations around the inventory transfer throughout the course of 2023, and the parties expect to be able to conclude these further negotiations in the coming months. The amount of stock which the Company will finally elect to purchase from DSM remains uncertain, and it will ultimately depend on (i) the best before dates of this inventory, which remain favourable / long dated in light of recent production runs of new Fruitflow material, (ii) recent stability data which suggests that the best before dates could be further extended, (iii) estimated customer demand in 2023/24 and beyond, (iv) the comparative costs and timing of a potential production run for a new batch of material and (v) the Company's financial resources at that time."
Thing is, If DSM was carrying in excess of €1m of stock surly they thought they would be able to sell it.
With “multiples of current revenue” to be filled and possibly 5 or more products to launch , you would think a large run is needed , I suppose if they produce new stock too early there could be a problem .
Just to clarify, when I say new stock I mean from the manufacturer and not the remaining stock that DSM holds.
Since the year end we should have purchased DSM stock of around £160k as we were contracted to do so.
" The Company has contractually committed to purchase more than €550k of Fruitflow inventory from DSM thus far, of which €348k was delivered and paid for in full in the quarter ended 31 March 2023. The remainder of the inventory which the Company has contractually committed to purchase from DSM is expected to be delivered and paid for in April 2023."
"At 31 March 2023 the Group had cash balances of £379,121"
"Sales in excess of £280k have been made post year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers"
My guess would be that IF is not looking to raise funds until we need a new stock of FF.
BWTFDIK :)
If I can make it to the AGM this year I have questions about funding 1/Ian why has it taken so long to address the funding issue ? Are you having problems ? 2/ this has been hanging over the heads of loyal shareholders for far too long a simple open offer could have sorted this a year ago why has this not happened .
Is anyone coming to the AGM. Just remember everyone our value is the patents. The more we have the higher the price when we get bought out. Last post for me till news comes as its hard to read the rubbish posted on here. Keep up the great work Gixer. I will/am adding as and when I can especially at these prices
Wtf is going on ,how low can we go
Anysight of a patent to help the wee blue pill
W-might-cause-a-big-rise-$
An impressive list of health benefits. I'm sure they apply to the general public, rather than shareholders, wherehair loss and blood pressure may be an issue? :-)
Looks like the relaunch is close.
https://www.facebook.com/ORIRIhealth
Hi gixer,
Many thanks for the wonderful findings. With all these patent approved, 18P will be very cheap option. It could be 118P.
“Some product registrations “ could mean any amount!
I’ve got a feeling when Bluehat is approved there’s going to be an awful lot of products released at the same time ! Imho
Got a few bases covered now.
Preventing hair loss and hair growth
Treatment of cerebral ischemia-reperfusion injury
Product with the effects of brightening skin
Function of improving memory
Reducing blood fat
Lowering of blood pressure
and more
https://patents.google.com/?q=(%22water-soluble+tomato%22)&assignee=%E6%B1%A4%E8%87%A3%E5%80%8D%E5%81%A5%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8&sort=new
Along with all the studies and the health function application for platelet aggregation you can't doubt By-Healths commitment.
Some did though.
"Application of water-soluble tomato concentrate in preparation of hair loss reducing and hair growing products"
https://patents.google.com/patent/CN116803404A/en
Another route to revenue.
Because the alliance agreement came to an end.
They might not have been given another option. But we have no idea what negotiations took place to come to the new agreement.
As for revenue.... I think this makes it clearer.
"Sales of the Fruitflow II SD ingredient in excess of £280k have been made in the six months after the Company's 31 March 2023 year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers for further direct sales of Fruitflow II SD in 2023 and beyond."
Thanks Alf , my thoughts as well , why would DSM sell the ff to pxs only to buy it back !
The wording is ambiguous I agree. I take it as 280k for the half year, with already 155k of not yet invoiced orders in the second half. If there are more incoming orders up to the end March 24, then the second half should easily exceed the first. I do think DSM would have tried to stock up as many as they could before handing the customer list over, so I don't think the 280k represents any particular level of sales that we can extrapolate. If that view is correct, there is reasonable optimism for non By Health sales going forward. Add the By Health potential, and we have another story completely IMHO
Alfista , can you give me your opinion of this statement from the finals ..”· The customer transfer process from DSM to Provexis has progressed well, and it saw initial sales of £74k in the quarter ended 31 March 2023, following the inventory transfer in February. Sales in excess of £280k have been made post year end, confirmed sales orders in excess of £155k are currently being processed and the Company is dealing with numerous sales enquiries from existing and new customers for further direct sales of Fruitflow in 2023 and beyond.”. . .. at first glance it looks encouraging £280k H1 and £155k for H2 ... but you can look at it as £280k income of which £155k is being processed . A bit concerning if that is the case . Imo
Big difference between retail produce sold at a premium, and commercial juicing tomatoes, where cost is the vital element.
I really shouldn't have to be pointing out the bleedin' obvious, but there it is.